Table 1.
Comparison of Enrollees with OUD in Sample Rural Counties Based on Primary Care Utilization, 2015
| Enrollees with an OUD Diagnosis | ||||
|---|---|---|---|---|
| All | Enrollees who did not have a primary care visit | Enrollees who had ≥ 1 primary care visit | p | |
| Number of enrollees, N (%) | 7930 | 3015 (38) | 4915 (62) | |
| Mean age, SD | 33.4 (9.8) | 30.9 (8.1) | 34.9 (10.4) | < 0.001 |
| 18–29 (%) | 3561 (44.9) | 1625 (53.9) | 1936 (39.4) | < 0.001 |
| 30–39 (%) | 2669 (33.7) | 1028 (34.1) | 1641 (33.4) | |
| 40–49 (%) | 1004 (12.7) | 247 (8.2) | 757 (15.4) | |
| 50–64 (%) | 696 (8.8) | 115 (3.8) | 581 (11.8) | |
| Female, N (%) | 4123 (52) | 1236 (41) | 2887 (58.7) | < 0.001 |
| Eligibility type, N (%) | ||||
| Disabled | 1562 (19.7) | 341 (11.3) | 1221 (24.8) | < 0.001 |
| Newly eligible | 4383 (55.3) | 2039 (67.6) | 2344 (47.7) | |
| Non-disabled adults | 1652 (20.8) | 578 (19.2) | 1074 (21.9) | |
| Other | 333 (4.2) | 57 (1.9) | 276 (5.6) | |
| Race, N (%) | ||||
| Non-Hispanic White | 7620 (96.1) | 2887 (95.8) | 4733 (96.3) | 0.562 |
| Non-Hispanic Black | 174 (2.2) | 74 (2.5) | 100 (2) | |
| Hispanic | 74 (0.9) | 31 (1) | 43 (0.9) | |
| Other | 62 (0.8) | 23 (0.8) | 39 (0.8) | |
| Enrollees with a behavioral health diagnosis, N (%) | ||||
| Anxiety disorder | 3369 (42.5) | 715 (23.7) | 2654 (54) | < 0.001 |
| Mood disorder | 3850 (48.6) | 937 (31.1) | 2913 (59.3) | < 0.001 |
| Schizophrenic and other psychotic disorders | 488 (6.2) | 127 (4.2) | 361 (7.3) | < 0.001 |
| Enrollees who received MAT, N (%) | 2361 (29.8) | 754 (25) | 1607 (32.7) | < 0.001 |
| Number of MAT fills, mean (SD) | 10.6 (8.3) | 9.3 (7.7) | 11.1 (8.5) | < 0.001 |
| Enrollees with a claim for counseling, N (%) | 3114 (39.3) | 1281 (42.5) | 1833 (37.3) | < 0.001 |
| Number of primary care Visits per person-year | 4.1 | 0 | 6.2 | |
| Number of primary care visits, mean (SD) | 3.5 (5.2) | 0 (0) | 5.6 (5.7) | |
| OUD diagnosed during PCP visit, N (%) | 1478 (18.6) | N/A | 1478 (30.1) | |
| Enrollees who received MAT among those diagnosed during PCP visit, N (%) | 751 (50.8) | N/A | 751 (50.8) | |
| Enrollees who received MAT from a PCP, among those diagnosed during PCP visit, N (%) | 508 (34.4) | N/A | 508 (34.4) | |
| Diagnosed with OUD in other places of service, N (%) | ||||
| ED Visit | 784 (9.9) | 283 (9.4) | 501 (10.2) | 0.243 |
| Acute care hospitalization | 589 (7.4) | 182 (6) | 407 (8.3) | < 0.001 |
| Behavioral health visit | 5684 (71.7) | 2474 (82.1) | 3210 (65.3) | < 0.001 |
| Other | 3688 (46.5) | 1198 (39.7) | 2490 (50.7) | < 0.001 |
MAT includes buprenorphine, injectable naltrexone, and oral naltrexone